Rationale

Antibiotic resistance, driven by antibiotic misuse, remains a serious concern within the healthcare community and the Global Respiratory Infection Partnership (GRIP) is committed to addressing this issue.

The GRIP believes that inappropriate prescriptions for upper respiratory tract infections (RTIs), including sore throat, is a leading cause of antibiotic overuse and subsequent resistance in the community. In addition, antibiotics do not provide the symptomatic relief patients need.

GRIP believes that antibiotics may not be indicated in the vast majority of upper RTIs and especially sore throats; instead symptomatic relief should form empirical treatment for patients.

GRIP is committed to antibiotic stewardship and conservancy by changing current Healthcare Professional and patient behaviour in the treatment of upper RTIs.